Examines major issues faced by Eli Lilly as it evaluates the adequacy of a focused matrix organization with extensive use of cross-functional teams.

Examines major issues faced by Eli Lilly as it evaluates the adequacy of a focused matrix organization with extensive use of cross-functional teams.
«Hide

from
Michael Y. Yoshino,
Thomas W. Malnight
Source: Harvard Business School
15 pages.
Publication Date: Jun 15, 1999. Prod #: 399174-PDF-ENG
Eli Lilly – 1998 (B): Emerging global organization HBR case solution